SPOREs : Information for the Public

Information for the Public: Activities of the SPORE Program

• Funding Information, Reports, and Announcements
• NCI Translational Science Meeting
• Co-Funding & Partnerships
• Organ Specific Workshops and Meetings
• Current Program Announcements
• Frequently Used Terms on This Site

Funding Information, Reports, and Announcements

NCI Translational Science Meeting

Co-Funding & Partnerships

Co-Funding of SPOREs

• National Institute of Dental and Craniofacial Research (NIDCR)
• National Institute of Neurological Disorders and Stroke (NINDS)

The AVON-NCI Progress for Patients (PFP) Awards Program   

In 2002, the Avon Foundation (AVON) and the National Institutes of Health (NIH) National Cancer Institute (NCI) announced the AVON-NCI Progress for Patients (PFP) Awards Program, a special private-public partnership to fund innovative research for preventing, detecting, diagnosing, and treating breast cancer. The objectives of the AVON-NCI PFP are to reduce time delays in performing early phase clinical trials, pilot, and validation studies as well as increase pipeline of agents/analyses/tests for Phase III trials. Moreover, AVON pledged $30 million to fund breast cancer research over 5 years through a limited competition involving institutions with NCI Cancer Center Support and Specialized Programs of Research Excellence (SPORE) grants. The NCI will continue to contribute funds, conduct peer reviews, and monitor project progress. Please be aware that the Program Announcement can be found at http://grants.nih.gov/grants/guide/pa-files/PAR-07-245.html and contains specific instructions that were added in 2007.

Additionally, it is important to note that the guidelines from previous years have been modified to include the following *NEW* requirements:

1. Each competitive supplement application should be submitted by the Principal Investigator of the parent P50 grant
2. Avon-NCI PFP applications will not be accepted when the proposed funding period extends beyond the end date of the parent P50 5-year project period
3. If investigators from other SPOREs/Cancer Centers are included in the application as subcontractors, the funding period of these subcontractors should not exceed their respective parent P50/P30 project period
4. Previously unfunded, revised projects must be resubmitted as new rather amended applications

• Brochure 2006 (PDF)
• Brochure 2005 (PDF)
• Brochure 2004 (PDF)
• Brochure 2003 (PDF)
• Press Release (October 1, 2002)

Organ Specific Workshops and Meetings

Current Program Announcements

The page is maintained by: Website Contact
The SPORE Program is not endorsing one specific non-governmental organization or site.